Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
Hunan Province Tumor Hospital
Hunan Province Tumor Hospital
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fox Chase Cancer Center
Shaare Zedek Medical Center
Shanghai Pulmonary Hospital, Shanghai, China
Case Comprehensive Cancer Center
RTOG Foundation, Inc.
Abramson Cancer Center at Penn Medicine
Barbara Ann Karmanos Cancer Institute
Abramson Cancer Center at Penn Medicine
The Netherlands Cancer Institute
Zhejiang Cancer Hospital
Dana-Farber Cancer Institute
Hoosier Cancer Research Network
Third Military Medical University
Hoosier Cancer Research Network
Massachusetts General Hospital
University of Washington
New Mexico Cancer Research Alliance
Dana-Farber Cancer Institute
Louisiana State University Health Sciences Center Shreveport
University of Alabama at Birmingham
Scripps Health